Increasing prevalence of pyomyositis is expected to drive the growth of pyomyositis market
Pyomyositis indicates swelling in body tissue which leads to the accumulation of pus caused by bacterial infection of skeletal muscles. Patients of all age group can be diagnosed with pyomyositis, majority of which includes children aged 2 to 5 years and patients with immunodeficiency disorders.
Pyomyositis can be treated by administration of antibiotics and surgical drainage in case of severe infection. According to study conducted in Uganda on pyomyositis, it is more prevalent in tropical regions and accounts for 1-4% hospitalization.
Pyomyositis market is expected to observe downfall amid Covid-19 due to the decline in hospitalization and surgical procedures across the globe. There has been a disruption in the supply and demand of pyomyositis treatment drugs due to shift in healthcare priorities and fear of infections in the healthcare facilities.
Ongoing clinical trials are expected to delay and short-term, negatively impacting the market. However, the shift will become normal in coming 1-2 years and expected to rise diagnosis and treatment rates of pyomyositis market.
Pyomyositis Market: Drivers and Restraints
Global pyomyositis market is anticipated to grow owing to increasing prevalence of the musculoskeletal surgical conditions in the future. Development of advanced surgical technologies are expected to accelerate the growth of the pyomyositis market in the future.
In addition, rising healthcare expenditure and early diagnosis is expected to boost global pyomyositis market. The rise in investments for research and development activities propelling the pyomyositis market growth.
Unavailability of effective treatment can hinder pyomyositis market growth. Generic drugs and biosimilar may hamper the growth of global pyomyositis market.
Pyomyositis Market: Overview
Pyomyositis treatment usually involves a combination of drugs, by drug class, antibiotics segment is expected to hold the largest share of revenue in the pyomyositis market. Oral route of administration is more prominent in the treatment of pyomyositis as compared to the parenteral route of administration.
Among distribution channels, the hospital pharmacies segment is projected to contribute the highest revenue in the pyomyositis market during the forecast period. Online pharmacies segment is estimated to observe fasted growing in the pyomyositis market due to increased penetration of e-commerce.
Pyomyositis Market: Region-wise Outlook
North America is expected to continue dominating the pyomyositis market owing to the high rate of prevalence in the region during the forecast period. Europe is the second lucrative region in pyomyositis market owing to early diagnosis and technological advancements.
Asia-Pacific pyomyositis market is estimated to have the highest growth owing to high patient pool and rise in medical tourism in the region. The Middle East and Africa pyomyositis market are still an untapped market with poor healthcare infrastructure and poor access to treatment.
Pyomyositis Market: Key Market Participants
Some of the key participants in the pyomyositis market identified are
- Novartis AG
- Merck & Co.
- Amgen Inc
- Bausch Health
- Pfizer Inc.
- Corbus Pharmaceuticals Holdings Inc.
- Inc. AbbVie Inc.
- GlaxoSmithKline plc.
- Milo Biotechnology
- CytRx Corporation
- Sanofi Promega
The research report on Pyomyositis market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.
It also contains projections using a suitable set of assumptions and methodologies. The research report on Pyomyositis market provides analysis and information according to market segments such as drug class, route of administration, application, and region.
The report covers exhaust analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Regional analysis includes:
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Europe (Germany, Italy, France, U.K, Spain, Russia)
- East Asia (China, Japan, South Korea)
- South Asia (India, ASEAN)
- Oceania (Australia, New Zealand)
- Middle East and Africa (GCC Countries, South Africa, Northern Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current, and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Pyomyositis Market: Segmentation
- Anti-Rheumatic Drugs
route of administration:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug stores
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.